PerkinElmer, Inc. Establishes ViaCord Research Institute™ to Further Cord Blood Stem Cell Advancements

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader in Health Sciences and Photonics, today announced the creation of the ViaCord Research Institute™ (VRI™) aimed at investigating new potential future uses of umbilical cord blood-derived stem cells. Led by a team of leading scientists and physicians, VRI will focus on supporting science, technology and medical treatments using cord blood stem cells in five key areas: cord blood technologies, emerging stem cell therapies, genetic screening, product development and related transplants.